A recent study expanded on the value of MyoStress® during needle-free stress testing inpatients with coronary artery disease (CAD), using another non-pharmacologic stress method: dynamic handgrip exercise (DHE). DHE may have the potential to address...
This article addresses the importance of having a new tool like MyoStrain® to detect patients with preserved Left Ventricle Ejection Fraction (LVEF). Traditional diagnostic metrics...
Following the November Cardiology Sumit Forum in Madrid, Dr. Eliseo Vañó Galván and Dr. José Luis Zamorano were interviewed by a reporter from Getafe Capital Periodico, a Madrid news publication, and a representative from....
Three abstracts utilizing MyoStrain, Myocardial Solutions’ patented technology, were accepted and presented at the distinguished annual American Heart Association (AHA) 2021 Scientific Sessions on November 13-15. The abstracts were based on studies conducted at....
A recent study evaluated the value of MyoStress, Myocardial Solutions’ proprietary software, during stress testing in patients with known or suspected coronary artery disease (CAD). MyoStress was compared to the gold-standard cardiac magnetic resonance (CMR) stress test....
